According to Puma Biotechnology's latest financial reports the company's current EPS (TTM) is -$0.05000. In 2022 the company made an earnings per share (EPS) of $0.0000000000 an increase over its 2021 EPS that were of -$0.71.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.05000 | -3.6028797018964E+17% |
2022 | $0.0000000000 | -100% |
2021 | -$0.71 | -52.98% |
2020 | -$1.51 | -22.96% |
2019 | -$1.96 | -34.45% |
2018 | -$2.99 | -61.91% |
2017 | -$7.85 | -5.42% |
2016 | -$8.30 | 11.56% |
2015 | -$7.44 | 57.63% |
2014 | -$4.72 | 148.42% |
2013 | -$1.90 | -44.93% |
2012 | -$3.45 | 483.38% |
2011 | -$0.59 | 103834.09% |
2010 | -$0.0005690 | -94.31% |
2009 | -$0.01000 | |
2008 | N/A |